These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 17482212)

  • 1. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample.
    Ganasen KA; Fincham D; Smit J; Seedat S; Stein D
    J Neurol Sci; 2008 Jun; 269(1-2):62-4. PubMed ID: 18237748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
    Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
    HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard.
    Davis HF; Skolasky RL; Selnes OA; Burgess DM; McArthur JC
    AIDS Read; 2002 Jan; 12(1):29-31, 38. PubMed ID: 11862658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalus.
    van Harten B; Courant MN; Scheltens P; Weinstein HC
    Dement Geriatr Cogn Disord; 2004; 18(1):109-14. PubMed ID: 15087586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample.
    Richardson MA; Morgan EE; Vielhauer MJ; Cuevas CA; Buondonno LM; Keane TM
    AIDS Care; 2005 Nov; 17(8):1013-21. PubMed ID: 16176897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center.
    Plummer DJ; Marcotte TD; Sample PA; Wolfson T; Heaton RK; Grant I; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):435-42. PubMed ID: 9950603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International HIV Dementia Scale: a new rapid screening test for HIV dementia.
    Sacktor NC; Wong M; Nakasujja N; Skolasky RL; Selnes OA; Musisi S; Robertson K; McArthur JC; Ronald A; Katabira E
    AIDS; 2005 Sep; 19(13):1367-74. PubMed ID: 16103767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function in HIV-seropositive Nigerians without AIDS.
    Salawu FK; Bwala SA; Wakil MA; Bani B; Bukbuk DN; Kida I
    J Neurol Sci; 2008 Apr; 267(1-2):142-6. PubMed ID: 18001772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AD8: a brief informant interview to detect dementia.
    Galvin JE; Roe CM; Powlishta KK; Coats MA; Muich SJ; Grant E; Miller JP; Storandt M; Morris JC
    Neurology; 2005 Aug; 65(4):559-64. PubMed ID: 16116116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
    Cysique LA; Maruff P; Brew BJ
    Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.